These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma. el-Yazigi A; Raines DA; Ali H; Sieck J; Ernst P; Dossing M Pharm Res; 1991 Feb; 8(2):269-72. PubMed ID: 2023880 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis. Harman AE; Priestly BG; Frewin DB Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875 [TBL] [Abstract][Full Text] [Related]
8. Saliva and plasma clearance of antipyrine as reflectors of liver function. Luoma PV; Sotaniemi EA Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccine and antipyrine clearance. Bachmann K; Schwartz J; Jauregui L; Forney R J Med; 1985; 16(4):453-9. PubMed ID: 2937866 [TBL] [Abstract][Full Text] [Related]
10. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060 [TBL] [Abstract][Full Text] [Related]
11. Antipyrine disposition in milk and saliva of lactating women. Berlin CM; Vesell ES Clin Pharmacol Ther; 1982 Jan; 31(1):38-44. PubMed ID: 7053302 [TBL] [Abstract][Full Text] [Related]
12. Liver failure and drug metabolism. Andreasen PB; Ranek L Scand J Gastroenterol; 1975; 10(3):293-7. PubMed ID: 1138332 [TBL] [Abstract][Full Text] [Related]
13. Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. Chang RL; Wood AW; Dixon WR; Conney AH; Anderson KE; Eiseman J; Alvares AP Clin Pharmacol Ther; 1976 Aug; 20(2):219-26. PubMed ID: 947654 [TBL] [Abstract][Full Text] [Related]
14. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva]. Janus K; Baranow-Baranowski S; Jakubowska D Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615 [TBL] [Abstract][Full Text] [Related]
15. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor. Buchanan N; Eyberg C; Davis MD Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967 [TBL] [Abstract][Full Text] [Related]
16. Impairment of antipyrine metabolism by low-dose oral contraceptive steroids. Abernethy DR; Greenblatt DJ Clin Pharmacol Ther; 1981 Jan; 29(1):106-10. PubMed ID: 7460468 [TBL] [Abstract][Full Text] [Related]
17. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation. Teunissen MW; Srivastava AK; Breimer DD Clin Pharmacol Ther; 1982 Aug; 32(2):240-6. PubMed ID: 7094512 [TBL] [Abstract][Full Text] [Related]
18. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs. Slørdal L; Høyem-Johansen T; Aarbakke J Pharmacology; 1983; 26(2):95-9. PubMed ID: 6844394 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory action of cimetidine on antipyrine metabolism. Piekoszewski W; Rutkowska A; Brandys J Pol J Pharmacol; 1993; 45(4):421-9. PubMed ID: 8118484 [TBL] [Abstract][Full Text] [Related]
20. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test]. von Mandach U; Jost G; Preisig R Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]